HOME >> MEDICINE >> NEWS
Sleep apnoea increases risks in general anaesthesia

Patients with obstructive sleep apnoea are at high risk of developing complications when having surgery under general anaesthesia, say researchers in this week's BMJ.

People with sleep apnoea temporarily stop breathing for 10 seconds or more during sleep. The typical sufferer is overweight and a heavy snorer. Obstructive sleep apnoea is the most common type, affecting 2% of women and 4% of men in middle age.

Surgeons of all specialties, and particularly anaesthetists, should be aware that obstructive sleep apnoea is undiagnosed in an estimated 80% of patients, say the authors. They should be alert to patients who are at risk of having obstructive sleep apnoea and be aware of the potential complications before and after surgery, even for surgery not related to the condition.

Options that should be considered include alternative methods of pain relief, use of nasal continuous positive airway pressure before and after surgery, and surveillance in an intensive care unit, especially after nasal surgery, conclude the authors.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
21-Oct-2004


Page: 1

Related medicine news :

1. Sleeping Through the Night: Childrens sleep expert advises parents
2. Sleeping less may be related to weight gain
3. Sleep duration affects appetite-regulating hormones
4. Sleep loss boosts appetite, may encourage weight gain
5. Sleep disorders often indicate multiple health conditions
6. Sleep apnea treatment could save lives & money by reducing auto accidents, according to researchers
7. Sleep problems in early childhood may predict substance use during adolescence
8. Sleep shortage takes toll on middle schoolers
9. Editorial in journal Sleep cites evidence of longer life with 6 to 7 hours sleep
10. Sleep apnea, depression linked in Stanford study
11. Sleep apnea treatment helps patients and partners

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
Cached News: